Scientists advise caution in immunotherapy research

Source: Ecancer News, February 2019

In a new study, Yale Cancer Centre (YCC) scientists suggest that as the number of clinical trials in cancer immunotherapy grows exponentially, some caution should be exercised as we continue to better understand the biology of these new therapeutic targets.

The findings are published today in the journal Cell.

Researchers around the world have been racing to create therapies that unleash the power of our immune systems against cancer.